Making metabolic therapies accessible globally
Through mechanism-driven metabolic reprogramming, we're developing oral, scalable treatments that target cellular pathways to transform patient outcomes.
Our mission
At Horeb Therapeutics, we believe transformative metabolic therapies should reach everyone who needs them. We're pioneering a new approach to drug development that combines deep mechanistic understanding with practical scalability.
By targeting specific cellular pathways involved in energy regulation, mitochondrial function, and inflammatory signaling, we're developing treatments that address root causes rather than symptoms.
What sets us apart
Our approach integrates cutting-edge science with a commitment to global accessibility
Mechanism Driven
Our approach targets specific cellular pathways involved in metabolic regulation, ensuring precision and efficacy at the molecular level.
Scalable & Accessible
Oral formulations designed with cost structure in mind, making transformative metabolic therapies accessible to populations worldwide.
Integrating formulation science, advanced pharmacokinetics, and human-relevant models to bridge the gap between discovery and clinical impact